Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
- Store in the original package to protect vials from light
- Store between 2 °C and 8 °C (36 °F and 46 °F) before reconstitution
STORAGE
AREXVY should be refrigerated. DO NOT FREEZE (discard if frozen)1
- After reconstitution, store between 2 °C and 8 °C (36 °F and 46 °F) or at room temperature up to 25 °C (77 °F) for up to 4 hours prior to use
- Discard reconstituted vaccine if not used within 4 hours
Nature and Contents of Container
Powder for 1 dose in a vial with stopper. Suspension for 1 dose in a vial with a stopper.1
Use and Handling
The powder and suspension should be inspected visually for any foreign particulate matter and/or variation of appearance. If either is observed, do not reconstitute the vaccine.1
Abbreviations
LRTD=lower respiratory tract disease; RSV=respiratory syncytial virus.
References
- Arexvy SPC, https://www.medicines.ie/medicines/arexvy-powder-and-suspension-for-suspension-for-injection-35441/spc. Accessed April 2024
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
©2024 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.
PM-IE-RSA-WCNT-230002 | May 2024
